The global market for 3D Microfluidic Organ Chip is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China 3D Microfluidic Organ Chip market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key 3D Microfluidic Organ Chip players cover Emulate, TissUse, Hesperos, CN Bio Innovations and Tara Biosystems, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This latest report provides a deep insight into the global 3D Microfluidic Organ Chip market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global 3D Microfluidic Organ Chip market, with both quantitative and qualitative data, to help readers understand how the 3D Microfluidic Organ Chip market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
The study segments the 3D Microfluidic Organ Chip market and forecasts the market size by Type (Brain-on-a-chip, Liver-on-a-chip and Kidney-on-a-chip), by Application (Hospital, Biotechnology and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Segmentation by application
Segmentation by region
Middle East & Africa
Major companies covered
CN Bio Innovations
Micronit Microtechnologies B.V.
Cherry Biotech SAS
Else Kooi Laboratory
Chapter 1: Scope of 3D Microfluidic Organ Chip, Research Methodology, etc.
Chapter 2: Executive Summary, global 3D Microfluidic Organ Chip market size (sales and revenue) and CAGR, 3D Microfluidic Organ Chip market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: 3D Microfluidic Organ Chip sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global 3D Microfluidic Organ Chip sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global 3D Microfluidic Organ Chip market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., etc.
Chapter 14: Research Findings and Conclusion